Microwave Ablation With Splenic Artery Occlusion for Secondary Hypersplenism — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Microwave Ablation With Splenic Artery Occlusion for Secondary Hypersplenism — Stella

Recruiting

Back to Secondary Hypersplenism trials

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

Trial locations(1 site)

China

Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin Municipality

Key details

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Enrollment target

~35 participants

Started

January 2024

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 65 Years

Last updated March 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov